Using a prime boost vaccination approach, Woodworth et al. observed that subcutaneous vaccination three times with a cationic adjuvanted protein-based TB vaccine (H56/CAF01) generated circulating CD4+ T-cells with accelerated lung-homing properties post-Mtb exposure (93). The gene discussed is CD4; the disease is tuberculosis.